mlive.com – Corewell Health will no longer provide [so-called] gender-affirming care to minors.
Noting the “serious risk of legal and regulatory action,” the health system said Thursday, Sept. 11, that it would stop prescribing puberty blockers or hormone therapy to minors for [so-called] gender affirmation.
“Like many health care systems across the country, we made this decision to protect both our health care providers and our patients,” Corewell said in a statement provided to MLive.
“We will continue to compassionately address the health needs of our patients who are in transition or wish to transition, including providing mental health support.”
Long-standing policy already prevented [so-called] gender-affirming surgeries on minors.
What it has offered was the use of puberty blockers, which delay onset or progression of puberty, and hormone therapy, which can be used to align someone’s physical appearance with their gender identity.
Corewell previously paused all gender-affirmation for new patients who are minors in February following an executive order from President Donald Trump.
The Jan. 28 order called for rigorous enforcement of all laws that prohibit or limit transition from one sex to another by anyone 18 or younger.
The health system quickly changed course and resumed service within a week, noting “care decisions are best made between physicians and families.”
Corewell’s latest pivot comes after Michigan Medicine announced it would no longer provide gender-affirming care for patients under 19. The Ann Arbor-based system cited a federal subpoena and “escalating external threats and risks.”
Existing Corewell patients who are minors and have been prescribed puberty blockers or hormone therapy for gender affirmation will be contacted by their care …
TODAY’S QUESTION: Should Donald Trump receive a Nobel Prize in medicine for his efforts toward ending gender manipulation of minors? Comment below.
